Big business ahead in VR-aided pain management

Dave Pearson | | Health Imaging | Artificial Intelligence

Virtual reality is believed effective in pain management for its ability to “swamp the brain” with so much sensory stimulation that some pain signals get crowded out. MRI studies have shown this effect in action.

In an Aug. 29 article, Bloomberg.com references the imaging research and looks at the potential for VR to grow as vendor competition heats up and prices come down: 

Hospitals Try Giving Patients a Dose of VR

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Generative AI increases efficiency, quality of radiology reports
FDA clears AI-assisted CCTA software that assesses plaques for signs of heart disease
AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
How AI and CCTA help heart teams plan ahead before PCI
5 steps for evaluating radiology AI applications

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.